To earn CME related to this news article, click here. January 26, 2009 — Anakinra is a relatively safe and modestly effective biologic therapy for rheumatoid arthritis (RA), according to a systematic ...

The interleukin (IL)-1 receptor antagonist anakinra (Kineret) was not superior to triamcinolone for relieving gout flares, but had similar effects for pain reduction as the glucocorticoid, a ...

Please provide your email address to receive an email when new articles are posted on . Anakinra did not increase days free from complications vs. placebo in patients with acute myocarditis. The drug ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “SARS-CoV-2 is thought to bind to toll-like receptors, ...

- Day 28 full results from the SAVE-MORE study show early treatment with anakinra plus SOC (standard of care) reduced mortality by 55% and reduced average time until ICU (intensive care unit) ...

Berlin, Germany - Two separate groups of researchers have reported cases in which patients with recalcitrant adult-onset Still's disease (AOSD) showed a prompt response to treatment with the ...

Amsterdam, Netherlands – 28 Aug 2023: The largest randomised controlled trial of patients with acute myocarditis has found that anakinra is safe but does not reduce complications. The late breaking ...

Newswise — Baylor Research Institute (BRI), the research arm of the Baylor Scott & White Health, announced that it has signed an agreement with Swedish Orphan Biovitrum AB (Sobi) to non-exclusively ...

A team of international scientists recently conducted an open-level clinical trial to investigate the effects of personalized immunotherapy on critically ill coronavirus disease 2019 (COVID-19) ...

The largest randomized controlled trial of patients with acute myocarditis has found that anakinra is safe but does not reduce complications. The late breaking research presented in a Hot Line session ...

Previous studies had indicated that treatments for the rare condition known as VEXAS were either not very effective or came with major side effects. Interleukin-1 inhibitors are among the treatments ...

The results of a randomized placebo-controlled trial show that the IL-1 receptor antagonist anakinra is safe and effective for the treatment of colchicine-resistant familial Mediterranean fever (FMF).